Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention: A Contemporary Review

Study Questions:

What is the optimal antiplatelet regimen in patients undergoing percutaneous coronary intervention (PCI) who are also taking a vitamin K antagonist (VKA) for atrial fibrillation (AF)?